Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE New Colombia Resources, Inc.
The Company is in discussions with Cannabis Science, Inc. (CBIS) to oversee clinical trials in Colombia.
MIAMI BEACH, Fla., May 9, 2014 /PRNewswire/ -- New Colombia Resources, Inc. (OTCQB: NEWC) ("New Colombia or the Company"), a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia. Dr. Janet Sweeney PhD and Corrie Yelland founders of the Phoenix Tears Foundation have been helping cancer patients with Cannabis based medicines while documenting their research since 2006. New Colombia Resources is also in discussions with Cannabis Science, Inc. (OTCQB: CBIS) to oversee clinical trials in Colombia.
The Phoenix Tears Foundation is the namesake of the world famous Phoenix Tears Oil, an extremely potent and sedative cannabis resin with 75-90% THC. They have documented this medicine curing several forms of cancer. The Phoenix Tears Foundation works with Patients Out of Time, a charity dedicated to educating health care professionals and the public about the therapeutic use of cannabis. This organization treats cancer patients in critical need. Most of these patients have no other alternative and have been told by their doctors there is nothing they can do. Within weeks of using the medicine they show remarkable improvement. In many cases the skin cancer is gone within months of using the oil. For more information and testimonials please visit www.phoenixtearsfoundation.com
"The U.S. federal government, legislators, law enforcement officers and many healthcare professionals often use the "lack of clinical trials" with cannabis as a legitimate reason for continuing the marijuana prohibition. The Catch 22 here is that the federal government has made it virtually impossible for researchers to study the therapeutic efficacy of cannabis. I believe legal clinical trials of Cannabis based medicines in Colombia will not only help Colombian cancer patients but will greatly benefit our efforts in the U.S.," stated Dr. Janet Sweeney PhD, co-founder of the Phoenix Tears Foundation.
New Colombia Resources and their scientific advisor, Dr. Robert Melamede PhD, President of Cannabis Science, Inc. (CBIS) are reviewing a proposal from a consulting firm establishing the procedures to begin clinical trials in Colombia. The Company has a clear path of the steps needed to gain an INVIMA approved product. The Company believes the data produced by clinical trials in Colombia can be used to support an FDA IND (Investigative New Drug) application.
About New Colombia Resources, Inc.
New Colombia Resources, Inc. is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They expect to have several revenue producing businesses including; metallurgical coal mining, African palm distribution, and traditional and organic coffees. They own 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15- 17 MM tonnes of reserves. They have another pending acquisition for 390 ha and a solicitation contract for 184 ha metallurgical coal concession. In May 2014 they are planting 3000 African palm trees to use as a showcase for a seedling and fertilizer distribution business. Once the necessary financing is obtained, the Company plans to have additional revenue producing business units in Colombia: coal mining, coking oven facilities, docks, river, and rail transportation to export terminals in Colombia. For more information on the Company visit www.newcolombiaresources.com.
Transportation, Logistics and Other Information
New Colombia Resources intends to sell their coal at the mine's gate unless they enter into off-take agreements. Upon proper financing, the Company plans to build or acquire river or rail loading facilities on the Magdalena River close to their mines. The coal will be trucked to these distribution centers, and then barged via the Magdalena River or by rail to terminals in Barranquilla, Santa Marta, or Cartagena for export. Initially they will use existing logistics providers while their transportation projects are being developed. After the rail projects and the "Road to the Sun" project are completed, New Colombia Resources will have one of a few metallurgical coal mines in the World with river, rail, and road access to coal export terminals on both the Atlantic and Pacific Oceans.
Forward Looking Statements
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations. New Colombia Resources, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
New Colombia Resources, Inc.
New Colombia Resources, Inc., mining subsidiary
Cia. Minera San Jose Ltda.
Kra. 3 # 2-52
(57) (1) 846-6579
©2012 PR Newswire. All Rights Reserved.